MUMBAI, India, June 20 -- Intellectual Property India has published a patent application (202321084365 A) filed by Cipla Limited, Maharashtra, on Dec. 11, 2023, for 'ready to use injectable formulation of potassium phosphate.'
Inventor(s) include Bhadauria, Pradeep; Kaliaperumal, Arunprasath; Rajyaguru, Tushar; Sharma, Harish; Jain, Ranjna; and Chaudhari, Laxmikant.
The application for the patent was published on June 20, under issue no. 25/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a ready- to- use injectable formulation of potassium phosphate and a process for preparing the same. The invention particularly relates to a ready-to-use injectable formulation comprising monobasic potassium phosphate, dibasic potassium phosphate, water for injection and optionally containing a tonicity adjusting agent."
Disclaimer: Curated by HT Syndication.
